Patent Protection

image136

Arête has filed national patent applications In the United States, Canada, The European Union, China, Japan, Australia, and India.  Our therapy has succeeded in stopping the progression of multiple sclerosis (MS) and Alzheimer's Disease in proof of concept mouse models.  We are currently conducting a proof of concept study in amyotrophic lateral sclerosis (ALS).  Future targets include Parkinson’s Disease, Hashimoto's Disease, Graves Disease, Crohn's Disease, ulcerative colitis, and more.